MS

Mangesh Subhashrao Chandore

Active Director Director DIN 08805670
DIN 08805670 First appointment Jul 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Mangesh Subhashrao Chandore

Data last updated:

Mangesh Subhashrao Chandore is a Director at Madhanjani Healthcare Private Limited (since 2020). The company operates in Healthcare.

DIN 08805670
Primary Designation Director
Industry Healthcare
First Appointment 23 Jul 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jul 20202020Active

Board colleagues of Mangesh Subhashrao Chandore

NameDINCompanyDesignation
Amol Subhashrao Chandore08805669Madhanjani Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Madhanjani Healthcare Private Limited
Premium access

Shareholding and investment profile for Mangesh Subhashrao Chandore

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mangesh Subhashrao Chandore

Mangesh Subhashrao Chandore currently holds 1 directorship: Madhanjani Healthcare Private Limited (Director, since 23 Jul 2020).

Mangesh Subhashrao Chandore was first appointed on 23 Jul 2020 as Director at Madhanjani Healthcare Private Limited.

The current boards of Mangesh Subhashrao Chandore's companies include Amol Subhashrao Chandore (Madhanjani Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available